The Jephcott Baronetcy, of East Portlemouth in the County of Devon, is a title in the
Baronetage of the United Kingdom. It was created on 14 February 1962 for the businessman
Harry Jephcott. He was notably Chairman of the
Glaxo Group
GSK plc, formerly GlaxoSmithKline plc, is a British multinational pharmaceutical and biotechnology company with global headquarters in London, England. Established in 2000 by a merger of Glaxo Wellcome and SmithKline Beecham. GSK is the tent ...
. As of 2014 the title has been held by his grandson, the fourth Baronet, who succeeded his father in 2012.
Jephcott baronets, of East Portlemouth (1962)
*
Sir Harry Jephcott, 1st Baronet (1891–1978)
*
Sir (John) Anthony Jephcott, 2nd Baronet (1924–2003)
*
Sir Neil Welbourn Jephcott, 3rd Baronet (1929–2012)
*
Sir David Welbourn Jephcott, 4th Baronet (born 1952)
The
heir presumptive
An heir presumptive is the person entitled to inherit a throne, peerage, or other hereditary honour, but whose position can be displaced by the birth of an heir apparent or a new heir presumptive with a better claim to the position in question.
...
is the present holder's brother Mark Lanwer Jephcott (born 1957).
The heir presumptive's
heir apparent
An heir apparent, often shortened to heir, is a person who is first in an order of succession and cannot be displaced from inheriting by the birth of another person; a person who is first in the order of succession but can be displaced by the b ...
is his son Richard Lanwer Jephcott (born 1989)
Notes
References
*Kidd, Charles, Williamson, David (editors). ''Debrett's Peerage and Baronetage'' (1990 edition). New York: St Martin's Press, 1990,
*{{Rayment-bt, date=March 2012
Jephcott